Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Zynx Health Announces Availability of Knowledge Analyzer

LOS ANGELES, July 22, 2014--Zynx Health™, the market leader in providing evidence- and experience-based clinical improvement solutions, has announced the general availability of Knowledge Analyzer™, a scalable solution that helps organizations quickly realize the full value of electronic health record (EHR) systems.

Thumbnail

N.J. health commissioner report pushes for full financial transparency for all hospitals

A report released late Friday by New Jersey’s health commissioner, Mary O’Dowd, recommends that the state require that all hospitals, public and private, for-profit and non-profit, publish their quarterly unaudited financial statements on their websites within 45 days of each quarter’s end, and their annual audits within 180 days of the close of a hospital’s fiscal year.

Thumbnail

Sunshine rule off to rocky start as doctors encounter error messages on reporting site

Physicians attempting to log in to the Open Payments website to verify information reported about them ahead of that information being made public are encountering a cumbersome log-in process and confusing error messages, reports ProPublica.

Thumbnail

Leapfrog hospital survey reveals wide variation in high-risk procedure survival rates and hospital-acquired injury and infection rates

The annual survey of hospital safety and quality by the non-profit Leapfrog Group and Castlight Health finds improvement and increased participation by hospitals, but also reflects a “surprisingly high variance” in high-risk procedure survival rates and hospital-acquired injury and infection rates.

Thumbnail

EHNAC launches ACO accreditation program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, is launching an accreditation program tailored to accountable care organizations and related IT service organizations.

Thumbnail

New NIH system aims to detect illicit drug trends

The National Institutes of Health has developed the National Drug Early Warning System so health experts can quickly respond to potential outbreaks of illegal drugs, like heroin, and identify increased use of designer synthetic compounds.

Thumbnail

Catholic Health Initiatives launches insurance subsidiary

The Englewood, Colorado-based mega hospital and healthcare non-profit network Catholic Health Initiatives is continuing to expand vertically as well as horizontally with its latest move to create a wholly-owned subsidiary called Prominence Health that will oversee its commercial and Medicare Advantage health-insurance plans, networks of care and related products.

Thumbnail

AHA/HRET hospital engagement network says it saved $1.3 billion over 2 years

One of the nation’s largest hospital engagement networks (HENs) is the more than 1,500-member HEN operated by the American Hospital Association (AHA) and its Health Research & Educational Trust (HRET). In its first 28 months of operation, it says it saved more than $1.3 billion by reducing the incidence of preventable harm, readmissions and infections, as well as the incidence of early elective deliveries.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.